Steven Cohn, MD, PhD, AGAF, FACG

Projects

Projects per year 2019 2020 2027

• 2 Completed
• 3 Active

Projects per year

Search results

• Active

  A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis.

  Cohn, S. (PI)

  Reistone Biopharma Company Limited ( Award # )

  1/19/22 → 1/18/27

  Project: Research project

• Protocol I6T-MC-AMBG (a) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis - LUCENT 2

  Cohn, S. (PI)

  Eli Lilly and Company ( Award # )

  5/13/20 → 5/12/25

  Project: Research project

• Corrona Inflammatory Bowel Disease (IBD) Registry

  Cohn, S. (PI)

  CorEvitas, LLC ( Award # )

  5/21/19 → 4/15/25

  Project: Research project

• Completed

  A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Controlled, Treat-Through study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease

  Cohn, S. (PI)

  Eli Lilly ( Award # )

  8/20/20 → 3/31/23

  Project: Research project

• A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.

  Cohn, S. (PI)

  Eli Lilly ( Award # )

  2/27/20 → 2/26/25

  Project: Research project